Standard Life Aberdeen »

Ascendis Pharma A S shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 139k 151.17
2023-12-31 $18M 139k 125.95

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Merck & Co (MRK)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Coca-Cola Company (KO)

View all positions for Standard Life Aberdeen

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
FMR
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
T. Rowe Price Investment Management
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Sofinnova Ventures
Brown Advisory Holdings Incorporated
Spyglass Capital Management
Alliancebernstein

View all funds holding Ascendis Pharma A S